(Q33373098)
Statements
1 reference
Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902. (English)
1 reference
Cancer and Leukemia Group B
1 reference
E Vokes
1 reference
C M Rocha-Lima
1 reference
J E Herndon
1 reference
M E Lee
1 reference
J N Atkins
1 reference
A Mauer
1 reference
M R Green
1 reference
25 October 2006
1 reference
1 reference
Identifiers
1 reference